Albert David (ADL) has entered into agreements with Zydus Healthcare (a wholly owned subsidiary of Cadila Healthcare) for the sale of ADL’s brand ‘Actibile’ with a free and marketable title along with all business information, know-how and the trademarks associated with the brand in territories of the Union of India; Nepal, South America (excluding Peru and Colombia), The United States of America; Japan, South Africa; the European Union; and East Europe, for a lump sum consideration of Rs 55.00 crore.
The transaction is a part of strategic initiative by Albert David and the proceeds front the sale will be invested for growth and expansion of the branded formulation business of the company.
Albert David manufactures pharmaceutical formulations and bulk drugs, infusion solutions and oral solids, disposable syringes and needles and herbal formulations.
